# Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains

> **NCT02263729** · PHASE1,PHASE2 · TERMINATED · sponsor: **James J. Irrgang** · enrollment: 8 (actual)

## Conditions studied

- Hamstring Injury

## Interventions

- **DRUG:** Losartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02263729
- **Lead sponsor:** James J. Irrgang
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-10
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The study was terminated due to difficulty identifying eligible participants and the expiration of funding.
- **Last updated:** 2024-05-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263729, "Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02263729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*